Clinicopathological characteristics and disease recurrence in patients with stage I EGFR-mutated lung adenocarcinomas (univariate analyses).

CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.

Jing Zhao
Julien Dinkel
Arne Warth
Roland Penzel
Niels Reinmuth
Philipp Schnabel
Thomas Muley
Michael Meister
Heike Zabeck
Martin Steins
Jian-Yong Yang
Qian Zhou
Heinz-Peter Schlemmer
Felix J F Herth
Hans-Ulrich Kauczor
Claus Peter Heussel

Comprehensively investigate the association of CT morphology and clinical findings of adenocarcinoma...

Image_3_Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis.TIF

Jianhao Qiu (9174170)
Zheng Ma (351144)
Rongyang Li (3760150)
Chenghao Qu (13036386)
Kun Wang (134525)
Binyan Liu (15268846)
Yu Tian (367745)
Hui Tian (322212)

December 2023

BackgroundThe progression of early stage non-small cell lung cancer (NSCLC) is closely related to ep...

Image_1_Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis.TIF

Jianhao Qiu (9174170)
Zheng Ma (351144)
Rongyang Li (3760150)
Chenghao Qu (13036386)
Kun Wang (134525)
Binyan Liu (15268846)
Yu Tian (367745)
Hui Tian (322212)

December 2023

BackgroundThe progression of early stage non-small cell lung cancer (NSCLC) is closely related to ep...

Clinical Characteristics, Tumor, Node, Metastasis Status, and Mutation Rate in Domain of Epidermal Growth Factor Receptor Gene in Serbian Patients with Lung Adenocarcinoma

Zaric, Bojan
Stojsic, Vladimir
Kovacevic, Tomi
Sarcev, Tatjana
Tepavac, Aleksandar
Jankovic, Radmila
Spasic, Jelena
Radosavljevic, Davorin
Zarogoulidis, Paul
Vukobradovic-Djoric, Nevena
Perin, Branislav

September 2014

ObjectiveMutation rate in domain of EGFR gene varies between populations of lung cancer patients. Pr...

Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma

Chao-Wen Lu
Mong-Wei Lin
Xu-Heng Chiang
Hsao-Hsun Hsu
Min-Shu Hsieh
Jin-Shing Chen

January 2023

The clinicopathological presentation of early-stage lung adenocarcinoma patients with epidermal grow...

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

Lu, Fangliang
Li, Shaolei
Dong, Bin
Zhang, Shanyuan
Lv, Chao
Yang, Yue

January 2016

Background: To evaluate differences in the clinical characteristics and molecular pathology of lung ...

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.

Jaeyoung Cho
Sun Mi Choi
Jinwoo Lee
Chang-Hoon Lee
Sang-Min Lee
Jae-Joon Yim
Doo Hyun Chung
Chul-Gyu Yoo
Young Whan Kim
Sung Koo Han
Young Sik Park

January 2016

BACKGROUND:The prognostic role of epidermal growth factor receptor (EGFR) mutations in patients with...

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas

Jaeyoung Cho (3353363)
Sun Mi Choi (477821)
Jinwoo Lee (243411)
Chang-Hoon Lee (196719)
Sang-Min Lee (474684)
Jae-Joon Yim (139591)
Doo Hyun Chung (135992)
Chul-Gyu Yoo (477823)
Young Whan Kim (477824)
Sung Koo Han (477825)
Young Sik Park (477822)

November 2016

<div>BackgroundThe prognostic role of epidermal growth factor receptor (EGFR) mutat...

Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma

Michelle Levy

December 2017

Activating epidermal growth factor receptor (EGFR) mutations in metastatic non-small cell lung cance...

Table_1_Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis.DOCX

Jianhao Qiu (9174170)
Zheng Ma (351144)
Rongyang Li (3760150)
Chenghao Qu (13036386)
Kun Wang (134525)
Binyan Liu (15268846)
Yu Tian (367745)
Hui Tian (322212)

December 2023

BackgroundThe progression of early stage non-small cell lung cancer (NSCLC) is closely related to ep...

Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy

Hondelink, Liesbeth M.
Ernst, Sophie M.
Atmodimedjo, Peggy
Cohen, Danielle
Wolf, Janina L.
Dingemans, Anne Marie C.
Dubbink, Hendrikus J.
von der Thüsen, Jan H.

March 2023

Objectives: The landmark ADAURA study recently demonstrated a significant disease-free survival bene...

Cytomorphological features as predictors of epidermal growth factor receptor mutation status in lung adenocarcinoma

Saniya Sharma
Nalini Gupta
Navneet Singh
Rini Chaturvedi
Digambar Behera
Arvind Rajwanshi

January 2018

Background: Epidermal growth factor receptor mutation-positive (EGFR-p) lung adenocarcinomas are sen...

Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy

Dal Maso A.
Lorenzi M.
Roca E.
Pilotto S.
Macerelli M.
Polo V.
Cecere F. L.
Del Conte A.
Nardo G.
Buoro V.
Scattolin D.
Monteverdi S.
Urso L.
Zulato E.
Frega S.
Bonanno L.
Indraccolo S.
Calabrese F.
Conte P.
Pasello G.

January 2020

Clinical features and disease course of patients with epidermal growth factor receptor (EGFR)-mutant...

EGFR and TTF-1 Gene Amplification in Surgically Resected Lung Adenocarcinomas: Clinicopathologic Significance and Effect on Response to EGFR-Tyrosine Kinase Inhibitors in Recurred Cases

김혜련
신미화
심효섭
이재석
이창영

January 2013

Background Gene amplifications are implicated in cancer development and progression. In this study w...

Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung adenocarcinoma (complex mutations are counted as separated mutation types here).

Kuo-Hsuan Hsu (628949)
Chao-Chi Ho (300272)
Te-Chun Hsia (534297)
Jeng-Sen Tseng (628945)
Kang-Yi Su (133405)
Ming-Fang Wu (113885)
Kuo-Liang Chiu (706343)
Tsung-Ying Yang (244469)
Kun-Chieh Chen (244491)
Hean Ooi (706344)
Tzu-Chin Wu (147095)
Hung-Jen Chen (567582)
Hsuan-Yu Chen (19228)
Chi-Sheng Chang (706345)
Chung-Ping Hsu (205422)
Jiun-Yi Hsia (706346)
Cheng-Yen Chuang (706347)
Chin-Hung Lin (706348)
Jeremy J. W. Chen (120767)
Kuan-Yu Chen (58762)
Wei-Yu Liao (300267)
Jin-Yuan Shih (59760)
Sung-Liang Yu (215636)
Chong-Jen Yu (58765)
Pan-Chyr Yang (19231)
Gee-Chen Chang (244418)

March 2015

Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung ad...

CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.

Jing Zhao
Julien Dinkel
Arne Warth
Roland Penzel
Niels Reinmuth
Philipp Schnabel
Thomas Muley
Michael Meister
Heike Zabeck
Martin Steins
Jian-Yong Yang
Qian Zhou
Heinz-Peter Schlemmer
Felix J F Herth
Hans-Ulrich Kauczor
Claus Peter Heussel

Comprehensively investigate the association of CT morphology and clinical findings of adenocarcinoma...

Image_3_Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis.TIF

Jianhao Qiu (9174170)
Zheng Ma (351144)
Rongyang Li (3760150)
Chenghao Qu (13036386)
Kun Wang (134525)
Binyan Liu (15268846)
Yu Tian (367745)
Hui Tian (322212)

December 2023

BackgroundThe progression of early stage non-small cell lung cancer (NSCLC) is closely related to ep...

Image_1_Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis.TIF

Jianhao Qiu (9174170)
Zheng Ma (351144)
Rongyang Li (3760150)
Chenghao Qu (13036386)
Kun Wang (134525)
Binyan Liu (15268846)
Yu Tian (367745)
Hui Tian (322212)

December 2023

BackgroundThe progression of early stage non-small cell lung cancer (NSCLC) is closely related to ep...

Clinical Characteristics, Tumor, Node, Metastasis Status, and Mutation Rate in Domain of Epidermal Growth Factor Receptor Gene in Serbian Patients with Lung Adenocarcinoma

Zaric, Bojan
Stojsic, Vladimir
Kovacevic, Tomi
Sarcev, Tatjana
Tepavac, Aleksandar
Jankovic, Radmila
Spasic, Jelena
Radosavljevic, Davorin
Zarogoulidis, Paul
Vukobradovic-Djoric, Nevena
Perin, Branislav

September 2014

ObjectiveMutation rate in domain of EGFR gene varies between populations of lung cancer patients. Pr...

Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma

Chao-Wen Lu
Mong-Wei Lin
Xu-Heng Chiang
Hsao-Hsun Hsu
Min-Shu Hsieh
Jin-Shing Chen

January 2023

The clinicopathological presentation of early-stage lung adenocarcinoma patients with epidermal grow...

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

Lu, Fangliang
Li, Shaolei
Dong, Bin
Zhang, Shanyuan
Lv, Chao
Yang, Yue

January 2016

Background: To evaluate differences in the clinical characteristics and molecular pathology of lung ...

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.

Jaeyoung Cho
Sun Mi Choi
Jinwoo Lee
Chang-Hoon Lee
Sang-Min Lee
Jae-Joon Yim
Doo Hyun Chung
Chul-Gyu Yoo
Young Whan Kim
Sung Koo Han
Young Sik Park

January 2016

BACKGROUND:The prognostic role of epidermal growth factor receptor (EGFR) mutations in patients with...

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas

Jaeyoung Cho (3353363)
Sun Mi Choi (477821)
Jinwoo Lee (243411)
Chang-Hoon Lee (196719)
Sang-Min Lee (474684)
Jae-Joon Yim (139591)
Doo Hyun Chung (135992)
Chul-Gyu Yoo (477823)
Young Whan Kim (477824)
Sung Koo Han (477825)
Young Sik Park (477822)

November 2016

<div>BackgroundThe prognostic role of epidermal growth factor receptor (EGFR) mutat...

Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma

Michelle Levy

December 2017

Activating epidermal growth factor receptor (EGFR) mutations in metastatic non-small cell lung cance...

Table_1_Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis.DOCX

Jianhao Qiu (9174170)
Zheng Ma (351144)
Rongyang Li (3760150)
Chenghao Qu (13036386)
Kun Wang (134525)
Binyan Liu (15268846)
Yu Tian (367745)
Hui Tian (322212)

December 2023

BackgroundThe progression of early stage non-small cell lung cancer (NSCLC) is closely related to ep...

Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy

Hondelink, Liesbeth M.
Ernst, Sophie M.
Atmodimedjo, Peggy
Cohen, Danielle
Wolf, Janina L.
Dingemans, Anne Marie C.
Dubbink, Hendrikus J.
von der Thüsen, Jan H.

March 2023

Objectives: The landmark ADAURA study recently demonstrated a significant disease-free survival bene...

Cytomorphological features as predictors of epidermal growth factor receptor mutation status in lung adenocarcinoma

Saniya Sharma
Nalini Gupta
Navneet Singh
Rini Chaturvedi
Digambar Behera
Arvind Rajwanshi

January 2018

Background: Epidermal growth factor receptor mutation-positive (EGFR-p) lung adenocarcinomas are sen...

Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy

Dal Maso A.
Lorenzi M.
Roca E.
Pilotto S.
Macerelli M.
Polo V.
Cecere F. L.
Del Conte A.
Nardo G.
Buoro V.
Scattolin D.
Monteverdi S.
Urso L.
Zulato E.
Frega S.
Bonanno L.
Indraccolo S.
Calabrese F.
Conte P.
Pasello G.

January 2020

Clinical features and disease course of patients with epidermal growth factor receptor (EGFR)-mutant...

EGFR and TTF-1 Gene Amplification in Surgically Resected Lung Adenocarcinomas: Clinicopathologic Significance and Effect on Response to EGFR-Tyrosine Kinase Inhibitors in Recurred Cases

김혜련
신미화
심효섭
이재석
이창영

January 2013

Background Gene amplifications are implicated in cancer development and progression. In this study w...

Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung adenocarcinoma (complex mutations are counted as separated mutation types here).

Kuo-Hsuan Hsu (628949)
Chao-Chi Ho (300272)
Te-Chun Hsia (534297)
Jeng-Sen Tseng (628945)
Kang-Yi Su (133405)
Ming-Fang Wu (113885)
Kuo-Liang Chiu (706343)
Tsung-Ying Yang (244469)
Kun-Chieh Chen (244491)
Hean Ooi (706344)
Tzu-Chin Wu (147095)
Hung-Jen Chen (567582)
Hsuan-Yu Chen (19228)
Chi-Sheng Chang (706345)
Chung-Ping Hsu (205422)
Jiun-Yi Hsia (706346)
Cheng-Yen Chuang (706347)
Chin-Hung Lin (706348)
Jeremy J. W. Chen (120767)
Kuan-Yu Chen (58762)
Wei-Yu Liao (300267)
Jin-Yuan Shih (59760)
Sung-Liang Yu (215636)
Chong-Jen Yu (58765)
Pan-Chyr Yang (19231)
Gee-Chen Chang (244418)

March 2015

Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung ad...

CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.

Jing Zhao
Julien Dinkel
Arne Warth
Roland Penzel
Niels Reinmuth
Philipp Schnabel
Thomas Muley
Michael Meister
Heike Zabeck
Martin Steins
Jian-Yong Yang
Qian Zhou
Heinz-Peter Schlemmer
Felix J F Herth
Hans-Ulrich Kauczor
Claus Peter Heussel

Comprehensively investigate the association of CT morphology and clinical findings of adenocarcinoma...

Image_3_Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis.TIF

Jianhao Qiu (9174170)
Zheng Ma (351144)
Rongyang Li (3760150)
Chenghao Qu (13036386)
Kun Wang (134525)
Binyan Liu (15268846)
Yu Tian (367745)
Hui Tian (322212)

December 2023

BackgroundThe progression of early stage non-small cell lung cancer (NSCLC) is closely related to ep...

Image_1_Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis.TIF

Jianhao Qiu (9174170)
Zheng Ma (351144)
Rongyang Li (3760150)
Chenghao Qu (13036386)
Kun Wang (134525)
Binyan Liu (15268846)
Yu Tian (367745)
Hui Tian (322212)

December 2023

BackgroundThe progression of early stage non-small cell lung cancer (NSCLC) is closely related to ep...

Clinicopathological characteristics and disease recurrence in patients with stage I <i>EGFR</i>-mutated lung adenocarcinomas (univariate analyses).

Abstract

Extracted data

Clinicopathological characteristics and disease recurrence in patients with stage I <i>EGFR</i>-mutated lung adenocarcinomas (univariate analyses).

Abstract

Extracted data

Related items

Related items